2026년 2월 10일 · Unknown · financial · 출처 Yahoo Finance
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.
RXO’s fair value estimate has been adjusted only modestly, from about US$15.50 to roughly US$15.89, but that small move reflects a meaningful shift in how analysts are thinking about the stock. A slightly lower discount rate alongside a firmer revenue growth outlook captures the current mix of optimism around capacity trends and AI execution, balanced against ongoing caution on timing and near term demand. Stay with this article to see how you can keep on top of these evolving assumptions so you are not caught off guard as the RXO narrative keeps shifting.
Stay updated as the Fair Value for RXO shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on RXO.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
Morgan Stanley’s Ravi Shanker upgraded RXO to Overweight from Equal Weight with a US$19 price target, highlighting confidence in the company’s AI efforts in brokerage and stating that normalized EPS is viewed at least at US$1, which supports a more constructive stance on execution and earnings power. Several firms, including TD Cowen and UBS, have raised price targets in recent months, which points to a cluster of analysts seeing support for RXO’s current valuation as they factor in tighter industry capacity and RXO’s positioning. TD Cowen’s Jason Seidl moved his target to US$14 from US$13 while keeping a Hold rating, citing survey work that points to regulation driven capacity attrition that could help the trucking group in 2026. This backdrop supports RXO’s revenue potential if it executes well. Susquehanna lifted its target to US$11 from US$10 and shifted to what it calls a more bullish valuation framework for the group, even as it keeps a Negative rating on RXO. This still feeds into the more supportive end of the target range compared with prior views.
🐻 Bearish Takeaways
JPMorgan and Stifel have each trimmed their RXO price targets by about US$1 in recent updates, signaling that some analysts see less upside at current levels and are baking in more caution around the near term setup. Citi reduced its target to US$15 from US$16 while maintaining a Neutral rating, indicating that although it sees a stronger sector backdrop tied to tighter capacity, it is not ready to assign RXO a higher valuation multiple based on current information. Susquehanna’s Negative rating, even alongside a higher US$11 target, underscores ongoing concerns about chasing the shares into softer seasonality and reflects reservations about how much upside is already priced in, especially around timing of any truckload recovery.
Story Continues
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!NYSE:RXO 1-Year Stock Price Chart
What's in the News
RXO reported goodwill impairment charges of US$12 million for the fourth quarter ended December 31, 2025, tied to its latest financial reporting period. This is a non cash accounting charge related to the value of acquired businesses or assets on the balance sheet. The impairment is classified under key developments for RXO, which means analysts and portfolio managers are likely incorporating this update into their ongoing models and opinion pieces on the stock. The goodwill charge is specific to the fourth quarter of 2025, so if you are comparing RXO’s recent results with prior periods, it is worth checking how this one time item is treated in any adjusted or non GAAP metrics you rely on.
How This Changes the Fair Value For RXO
Fair Value: The analyst fair value estimate edges up slightly from about US$15.50 to roughly US$15.89. Discount Rate: The discount rate assumption is trimmed modestly from about 8.53% to around 8.46%. Revenue Growth: The revenue growth expectation moves from roughly 3.94% to about 4.71%. Net Profit Margin: The net profit margin assumption increases from about 0.91% to roughly 1.32%. Future P/E: The future P/E multiple assumption is reduced from about 54.1x to around 38.7x.
🔔 Never Miss an Update: Follow The Narrative
Narratives on Simply Wall St let you connect a company’s story with the numbers behind it. You set out your view on RXO’s business, link that view to forecasts for revenue, earnings and margins, and arrive at a fair value you can compare to the current share price. Narratives live on the Community page, update automatically when fresh news or earnings land, and give you a simple way to decide whether RXO looks expensive, cheap or fairly priced on your terms.
If you want the full context behind RXO’s fair value, forecasts and risks, read and follow the original Narrative on RXO here: RXO: AI Execution And Capacity Tightness Will Shape Balanced EPS Normalization Prospects, and keep an eye on it for updates as the data changes.
It connects RXO’s AI freight matching, LTL brokerage growth and asset light model to specific revenue, margin and earnings forecasts through about 2028, including an assumed 7.3% annual revenue growth rate and margins moving from a loss position to 1.9%. It spells out the conditions analysts are using for RXO’s fair value, such as earnings of US$132.5m, a P/E of 27.1x and a consensus price target of US$16.24, so you can judge whether those inputs match your own expectations. It clearly lays out the key risks around freight softness, automotive exposure, integration of Coyote and competition in brokerage, helping you decide how much uncertainty you are comfortable with before you commit capital or adjust your position.
Curious how numbers become stories that shape markets? Explore Community Narratives
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles …